Prices for insulin, the essential drug for treating diabetes, have plummetted to their lowest levels in a decade following a ...

The biosimilars – which will be interchangeable with Sanofi's Lantus (insulin glargine), Novo Nordisk's Novolog (insulin aspart) and Eli Lilly's Humalog (insulin lispro) – will be priced at no ...

Humalog and Humalin, by 70% by the end of the year. It is also dropping the list price of its non-branded insulin, Lispro, to $25 a vial, effective 1 May. "While the current healthcare system ...

Prices of insulin have continued to climb ... Patients will have a harder time getting their Humalog and Insulin Lispro Injections at wholesalers and pharmacies through the beginning of next ...